AGIOS PHARMACEUTICALS, INC. Common Stock, Value, Issued
AGIOS PHARMACEUTICALS, INC. (AGIO) had Common Stock, Value, Issued of $71.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2022-08-04
- 2022-06-30: Common Stock, Value, Issued $71.00K.
- 2022-03-31: Common Stock, Value, Issued $71.00K.
- 2021-12-31: Common Stock, Value, Issued $71.00K.
- 2021-09-30: Common Stock, Value, Issued $71.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2022-06-30 | $71.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $71.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $71.00K 10-Q · filed 2022-08-04 |
| 2021-09-30 | $71.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $70.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $70.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $69.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $69.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $69.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $69.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $68.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $59.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $59.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $59.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $58.00K 10-K · filed 2020-02-19 |
| 2018-09-30 | $58.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $58.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $58.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $49.00K 10-K · filed 2019-02-14 |
| 2017-09-30 | $49.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $48.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $42.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $42.00K 10-K · filed 2018-02-14 |
| 2016-09-30 | $42.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $38.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $38.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $38.00K 10-K · filed 2017-02-16 |
| 2015-09-30 | $38.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $37.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $37.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $37.00K 10-K · filed 2016-02-26 |
| 2014-09-30 | $35.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $34.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $32.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $31.00K 10-K · filed 2015-02-24 |
| 2013-09-30 | $31.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $4.00K 10-Q · filed 2013-09-05 |
| 2012-12-31 | $3.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |